New Delhi, Oct. 13 -- The Supreme Court on Monday told the Centre to show urgency in the matter of regulating prices of life saving drugs and devices even as the government said anti-cancer drugs will now be significantly reduced by up to 70% with the recent decision to cap the trade margin of these drugs at 30% of the maximum retail price. "How does the manufacturer fix a price and sell it at a price to retailer which is one-tenth or one-fifth of the MRP.Can there be anything more important than this in the entire country," the bench of justices Vikram Nath and Sandeep Mehta said. The decision of the Centre was disclosed to the court in an affidavit filed by department of pharmaceuticals, ministry of chemicals and fertilizers on Monday dur...